Nutrabolt

C4 Extreme Cherry Limeade

C-
N+ Score69
CreatineServing: 5.8 Gram(s)Type: Other Combinations

Nutrabolt C4 Extreme Cherry Limeade is a pre-workout combination supplement containing 8 ingredients. It includes CarnoSyn at a clinically studied dose of 2 grams, which research suggests may support athletic performance. Other notable ingredients are Citrulline Nitrate (1 gram), Creatine Nitrate (1 gram), and Caffeine (200mg). However, N-Acetyl L-Tyrosine is present at an underdosed level of 200mg. The product received an N+ Score of 69, corresponding to a C- grade, indicating average overall quality. It may be suitable for individuals seeking a pre-workout formula with some effectively dosed components.

About This Product

C4 Extreme Cherry Limeade by Nutrabolt is a creatine supplement containing 8 active ingredients. It has earned an N+ Score of 69/100 (Grade C-).

Notable clinical-dose ingredients include CarnoSyn.

N+ Score Breakdown

Ingredient Adequacy25/100

Are key ingredients present at clinically effective doses based on research?

Formula Completeness100/100

Does the product include all expected ingredients for its supplement category?

Label Transparency75/100

Are individual ingredient amounts clearly disclosed without proprietary blends?

Ingredient Diversity100/100

Does the formula include a breadth of beneficial compounds from multiple pathways?

Strengths

  • +Comprehensive formula with expected ingredients for its category
  • +Fully transparent label with individual ingredient amounts disclosed
  • +Broad ingredient diversity exceeding category norms
  • +1 ingredient(s) at clinical dose levels

Weaknesses

  • −Several ingredients below clinically effective doses

Ingredient Analysis (8 ingredients)

IngredientAmountDose Adequacy
Calories—N/A
Total Carbohydrates—N/A
CarnoSyn2.000 Gram(s)Adequate
Caffeine200.000 mgN/A
Creatine Nitrate1.000 Gram(s)N/A
N-Acetyl L-Tyrosine200.000 mgUnder
Huperzine A50.000 mcgN/A
Citrulline Nitrate1.000 Gram(s)N/A

Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.